CMS reimbursements

CMS Will Cover Approved Alzheimer’s Drugs, But It Still Wants More Evidence

Medicare will cover Alzheimer’s disease drugs granted traditional FDA approval, CMS announced. But the decision keeps the spirit of an earlier coverage determination, which called for the gathering of more evidence about the safety and efficacy of these therapies.

By Frank Vinluan

Consumer / Employer, MedCity Influencers, Physicians

Short-term fixes underscore the need for long-term Medicare reform

What specialty providers and seniors need is a sustainable solution to preserve the federal health insurance program and properly reimburse providers.

By Nikesh Patel

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.